These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8108529)

  • 1. [Development of symptoms, complications, and treatment of panic disorder--on agoraphobia, other phobias, and personality disturbances].
    Kadota I; Sasaki H; Kawatani D; Nishizono M
    Seishin Shinkeigaku Zasshi; 1993; 95(11):874-9. PubMed ID: 8108529
    [No Abstract]   [Full Text] [Related]  

  • 2. Comorbidity and its effects on panic disorder.
    Marshall JR
    Bull Menninger Clin; 1996; 60(2 Suppl A):A39-53. PubMed ID: 8857426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-injury related phobic avoidance as predictor of nonresponse to pharmacotherapy in panic disorder with agoraphobia.
    Overbeek T; Büchold H; Schruers K; Griez E
    J Affect Disord; 2004 Mar; 78(3):227-33. PubMed ID: 15013247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
    Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P
    Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened embarrassability discriminates between panic disorder patients with and without agoraphobia.
    Swoboda H; Demal U; Krautgartner M; Amering M
    J Behav Ther Exp Psychiatry; 2003; 34(3-4):195-204. PubMed ID: 14972667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron in the treatment of panic disorder.
    Schneier FR; Garfinkel R; Kennedy B; Campeas R; Fallon B; Marshall R; O'Donnell L; Hogan T; Liebowitz MR
    Anxiety; 1996; 2(4):199-202. PubMed ID: 9160623
    [No Abstract]   [Full Text] [Related]  

  • 7. Panic disorder with and without agoraphobia: comorbidity within a half-year of the onset of panic disorder.
    Kikuchi M; Komuro R; Oka H; Kidani T; Hanaoka A; Koshino Y
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):639-43. PubMed ID: 16401237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panic disorder and phobic avoidance.
    Maddock R
    Am J Psychiatry; 1987 Dec; 144(12):1625-6. PubMed ID: 3688298
    [No Abstract]   [Full Text] [Related]  

  • 9. Change in interpersonal problems after cognitive agoraphobia and schema-focused therapy versus psychodynamic treatment as usual of inpatients with agoraphobia and Cluster C personality disorders.
    Gude T; Hoffart A
    Scand J Psychol; 2008 Apr; 49(2):195-9. PubMed ID: 18352990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical picture and treatment of agoraphobia with panic disorder].
    Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
    Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
    [No Abstract]   [Full Text] [Related]  

  • 11. Panic disorder and the onset of agoraphobia.
    Herrán A; Carrera M; Sierra-Biddle D; Ramírez L; Rodríguez-Cabo B; Ayestarán A; Hoyuela F; Vázquez-Barquero JL
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):395-6. PubMed ID: 16732761
    [No Abstract]   [Full Text] [Related]  

  • 12. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 13. Lamotrigine administration in panic disorder with agoraphobia.
    Masdrakis VG; Papadimitriou GN; Oulis P
    Clin Neuropharmacol; 2010 May; 33(3):126-8. PubMed ID: 20502131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of comorbid personality disorders in patients with panic disorder with agoraphobia.
    Latas M; Starcevic V; Trajkovic G; Bogojevic G
    Compr Psychiatry; 2000; 41(1):28-34. PubMed ID: 10646616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of sensation-focused intensive treatment for panic disorder with moderate to severe agoraphobia: preliminary outcome and benchmarking data.
    Bitran S; Morissette SB; Spiegel DA; Barlow DH
    Behav Modif; 2008 Mar; 32(2):196-214. PubMed ID: 18285506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodromal symptoms in panic disorder with agoraphobia: a replication study.
    Fava GA; Grandi S; Rafanelli C; Canestrari R
    J Affect Disord; 1992 Oct; 26(2):85-8. PubMed ID: 1447431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory distress during panic attacks associated with agoraphobia.
    Pollard CA
    Psychol Rep; 1986 Feb; 58(1):61-2. PubMed ID: 3961082
    [No Abstract]   [Full Text] [Related]  

  • 20. [The first panic attack: a missed chance for prevention of panic disorder and its complications].
    Amering M; Berger P; Dantendorfer K; Windhaber J; Katschnig H
    Psychiatr Prax; 1997 Mar; 24(2):65-8. PubMed ID: 9190611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.